Andritz to Supply New PrimeLineCOMPACT Tissue Machine to PMI in Algeria
Print this Article | Send to Colleague
International technology Group Andritz has received an order from Paper Mill Investment (PMI) to supply a tissue machine with steel Yankee and shoe press to Algeria. The new plant will produce high-quality facial wipes as well as toilet and towel papers. Start-up is scheduled for the first quarter of 2018.
The new PrimeLineCOMPACT tissue machine has a design speed of 2,000 m/min and a paper width of 2.85 m. The order includes a complete Andritz stock preparation for virgin pulp with a capacity of 135 bdtonnes/day.
The tissue machine is equipped with the latest shoe press technology (PrimePress XT Evo). Thanks to the energy-efficient design, improved dewatering, and reduced need for thermal drying, the shoe press minimizes energy consumption. The 16-ft PrimeDry Yankee is made entirely of steel and enables a high drying capacity.
Paper Mill Investment (PMI) is a new innovative paper manufacturing company founded by people with longtime and profound experience in the paper making industry. Its expansion plans include paper mills in several countries of the MENA region.
Andritz is a globally leading supplier of plants, equipment, and services for hydropower stations, the pulp and paper industry, the metalworking and steel industries, and for solid/liquid separation in the municipal and industrial sectors as well as for animal feed and biomass pelleting. Other important business segments include automation and service business. In addition, the international Group is also active in the power generating sector (steam boiler plants, biomass boilers, recovery boilers, and gasification plants) and in environmental technology (flue gas cleaning plants) and offers equipment for the production of nonwovens, dissolving pulp, and panelboard as well as recycling plants. The company is headquartered in Graz, Austria, and has a staff of approximately 25,200 employees. Andritz operates more than 250 sites in over 40 countries.
Back to Tissue360 Newsletter |